Biocartis Group N.V.
BIOGF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $57,481 | $48,269 | $43,128 | $37,444 |
| % Growth | 19.1% | 11.9% | 15.2% | – |
| Cost of Goods Sold | $29,799 | $33,922 | $26,284 | $21,328 |
| Gross Profit | $27,682 | $14,347 | $16,844 | $16,116 |
| % Margin | 48.2% | 29.7% | 39.1% | 43% |
| R&D Expenses | $38,393 | $48,054 | $40,927 | $39,844 |
| G&A Expenses | $3,524 | $3,321 | $3,162 | $5,254 |
| SG&A Expenses | $8,573 | $6,403 | $6,541 | $9,813 |
| Sales & Mktg Exp. | $5,049 | $3,082 | $3,379 | $4,559 |
| Other Operating Expenses | $27,467 | $0 | $0 | $0 |
| Operating Expenses | $74,433 | $76,645 | $63,226 | $71,461 |
| Operating Income | -$47,047 | -$62,645 | -$46,862 | -$55,602 |
| % Margin | -81.8% | -129.8% | -108.7% | -148.5% |
| Other Income/Exp. Net | -$18,574 | -$9,070 | -$16,300 | -$8,565 |
| Pre-Tax Income | -$65,621 | -$71,715 | -$63,162 | -$64,167 |
| Tax Expense | -$240 | -$243 | -$228 | -$99 |
| Net Income | -$65,381 | -$71,472 | -$62,934 | -$64,068 |
| % Margin | -113.7% | -148.1% | -145.9% | -171.1% |
| EPS | -1.08 | -1.24 | -1.11 | -1.14 |
| % Growth | 12.9% | -11.7% | 2.6% | – |
| EPS Diluted | -1.08 | -1.24 | -1.11 | -1.14 |
| Weighted Avg Shares Out | 60,546 | 57,545 | 56,610 | 56,074 |
| Weighted Avg Shares Out Dil | 60,546 | 57,546 | 56,611 | 56,075 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,077 | $0 | $0 |
| Interest Expense | $11,187 | $9,320 | $10,184 | $7,099 |
| Depreciation & Amortization | $10,481 | $9,845 | $9,748 | $9,719 |
| EBITDA | -$43,953 | -$52,550 | -$43,230 | -$47,349 |
| % Margin | -76.5% | -108.9% | -100.2% | -126.5% |